Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

GSK to cut up to 350 R&D jobs across UK, US

(Sharecast News) - GSK is planning to cut as many as 350 jobs in research & development in the UK and US, it was announced on Monday. It was understood the company is planning to axe around 50 roles at its main R&D hub in Stevenage, Hertfordshire.

A spokesperson for the drugs giant said in a statement: "GSK R&D investment has risen by almost 90% over recent years (to £6.4bn in 2024) and we expect it to increase further as we focus on delivering our pipeline of new medicines with multi-blockbuster potential before 2031.

"As we increase investment, we're focused on allocating resources to these priorities and making sure we have the right people in the right teams. Alongside this, we're investing in technology to maximise our scientific capabilities and drive productivity, and in our key R&D sites over the next five years to accelerate drug discovery and research."

Share this article

Related Sharecast Articles

Air France-KLM submits bid for stake in Portugal's TAP
(Sharecast News) - Air France-KLM said it had submitted a non-binding offer to buy a minority stake in TAP Air Portugal as part of the Portuguese government's plan to privatise its national airline.
Sorted Group proposes to dispose of its main trading subsidiary
(Sharecast News) - Sorted Group announced a proposal to dispose of its main trading subsidiary Sorted Group Limited on Thursday, for a nominal £1, in a move that would see the company become an AIM cash shell and pursue a new acquisition-led strategy.
Speedy Hire warns on worsening market conditions despite strategic progress
(Sharecast News) - Tools and equipment hire company Speedy Hire said on Thursday that it had delivered "significant strategic progress" in FY26, highlighted by its "transformational" partnership with Proservice and continued momentum across its core operations, but also cautioned that trading conditions had deteriorated further in the final quarter amid budget uncertainty, geopolitical tensions and customer‑driven delays.
RBC Capital Markets upgrades Berkeley to 'outperform'
(Sharecast News) - Analysts at RBC Capital Markets upgraded housebuilder Berkeley from 'sector perform' to 'outperform' on Thursday, noting the group had "acted decisively" to the challenges it had faced.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.